Location History:
- Oceanport, NJ (US) (2011 - 2014)
- Salt Lake City, UT (US) (2012 - 2018)
Company Filing History:
24 out of 59 
1 out of 832,880 Years Active: 2011-2018
Title: Bruce Hopenfeld: Innovator in Cardiac Event Detection Technologies
Introduction
Bruce Hopenfeld is a prominent inventor based in Salt Lake City, UT, USA, known for his significant contributions to the field of cardiac event detection. With an impressive portfolio of 25 patents, he has developed innovative systems that enhance the diagnosis and monitoring of heart conditions.
Latest Patents
Among Hopenfeld's latest patents are groundbreaking inventions such as the "Waveform feature value averaging system and methods for the detection of cardiac events." This patent discloses a sophisticated system designed to detect pathophysiological cardiac conditions. The system features a diagnostic device equipped with electronic circuitry capable of identifying cardiac events like acute ischemia. It processes signals from subcutaneous or body surface sensors to compute critical measurements pertaining to cardiac activity.
Another noteworthy patent is the "Posture dependent time series filtering system and methods for the detection of cardiac events." This device utilizes a parameter that varies according to heart rate to detect cardiac events. It employs exponential average filters to separate datasets associated with various body postures, allowing for precise detection of events based on heart rate and parameter thresholds.
Career Highlights
Bruce Hopenfeld has had a distinguished career, having contributed to notable advancements in medical technologies. He has worked with Angel Medical Systems Inc., where he played a pivotal role in the development of innovative cardiac care solutions. His dedication to research and development is reflected in his extensive patent portfolio.
Collaborations
Throughout his career, Hopenfeld has collaborated with esteemed professionals in the field, including David R. Fischell and Steven R. Johnson. These collaborations have fostered innovation and propelled advancements in cardiac diagnostics, allowing for improved patient care.
Conclusion
With a wealth of experience and a commitment to innovation, Bruce Hopenfeld continues to shape the landscape of cardiac event detection technology through his patents and collaborations. His work not only demonstrates his expertise as an inventor but also emphasizes the importance of continuous advancement in medical technology for better health outcomes.